Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
Titel:
Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
Auteur:
Kim, S.T. Kang, J.H. Lee, J. Lee, H.W. Oh, S.Y. Jang, J.S. Lee, M.A. Sohn, B.S. Yoon, S.Y. Choi, H.J. Hong, J.H. Kim, M.-J. Kim, S. Park, Y.S. Park, J.O. Lim, H.Y.